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Abstract
Background: Profilin is a small cytoskeletal protein which interacts with actin, proline-rich
proteins and phosphatidylinositol 4,5-bisphosphate (PI(4,5)-P2). Crystallography, NMR and
mutagenesis of vertebrate profilins have revealed the amino acid residues that are responsible for
the interactions with actin and poly(L-proline) peptides. Although Arg88 of human profilin I was
shown to be involved in PI(4,5)-P2-binding, it was suggested that carboxy terminal basic residues
may be involved as well.
Results : Using site directed mutagenesis we have refined the PI(4,5)-P2 binding site of human
profilin I. For each mutant we assessed the stability and studied the interactions with actin, a
proline-rich peptide and PI(4,5)-P2 micelles. We identified at least two PI(4,5)-P2-binding regions in
human profilin I. As expected, one region comprises Arg88 and overlaps with the actin binding site.
The second region involves Arg136 in the carboxy terminal helix and neighbours the poly(L-
proline) binding site. In addition, we show that adding a small protein tag to the carboxy terminus
of profilin strongly reduces binding to poly(L-proline), suggesting local conformational changes of
the carboxy terminal α -helix may have dramatic effects on ligand binding.
Conclusions : The involvement of the two terminal α -helices of profilin in ligand binding imposes
important structural constraints upon the functions of this region. Our data suggest a model in
which the competitive interactions between PI(4,5)-P2 and actin and PI(4,5)-P2 and poly(L-proline)
regulate profilin functions.
Background
The small actin binding protein profilin has multiple
binding partners and is thought to play a key-role in the
regulation of actin dynamics [1–5]. Originally, profilin
was identified as an actin sequestering protein but recent-
ly more complex effects on actin polymerization have
been proposed because actin-profilin complexes can add
to free barbed ends thereby stimulating actin polymeriza-
tion [6,7].
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Profilins bind poly(L-proline) sequences and many pro-
teins containing proline-rich stretches have been identi-
fied as profilin ligands. Of these the interaction with the
enabled/vasodilator stimulated phosphoprotein (Ena/
VASP) family is best documented [8–10]. For several pro-
line-rich proteins a direct link with signal transduction
pathways has been described [11–13], thus positioning
profilins at crossroads of multiple pathways that lead to
actin remodeling [5]. With the elucidation of the profilin-
β -actin crystal structure, the residues at the interface of
both proteins were identified [1]. Additionally, crystalo-
graphic, mutagenesis and spectroscopic studies have ad-
dressed the poly(L-proline) binding site and showed that
a hydrophobic pocket between the amino and carboxy
terminal α -helices forms the binding site for poly(L-pro-
line) sequences [2,14–19].
The interaction of profilin with phosphatidylinositol lip-
ids has been functionally studied. In vitro, PI(4,5)-P2 dis-
sociates actin:profilin complexes [3] and these and other
authors also demonstrated the specificity of the interac-
tion between profilin I and PI(4,5)-P2 in both micellar
form as well as in lipid vesicles [20,21]. More recently it
was shown that phosphatidylinositol (3,4)-bisphosphate
and phosphatidylinositol (3,4,5)-triphosphate bind to
profilin with even higher affinity than PI(4,5)P2 and that
phosphatidylinositol (3,4,5)-triphosphate inhibits profi-
lin sequestering activity much better than PI(4,5)P2[22].
In addition, PI(4,5)-P2, bound to profilin, can only be hy-
drolyzed by phospholipase Cγ 1 (PLCγ 1), when this lipase
is phosphorylated and activated, which occurs in response
to transmembrane signaling [21,23]. This leads to two,
not mutually exclusive scenarios that profilins are in-
volved in phosphoinositide metabolism or that PI(4,5)-
P2 hydrolysis causes translocation of profilin from the
membrane to the cytosol where it can interact with actin
or other ligands. This suggests an important role for profi-
lin-phosphoinositide interaction in vivo[24,25]. The struc-
tural basis for this interaction is, however, only partly
resolved (see below).
The interaction of actin binding proteins with PI(4,5)-P2
is usually assigned to the binding of the negatively
charged headgroup of the phoshoinositide to basic amino
acids. In agreement with this is that the more positivily
charged Acanthamoeba profilin II isoform has highest af-
finity for PI(4,5)-P2[26]. Similarly, the more basic human
profilin I isoform interacts better with PI(4,5)-P2 than
does profilin IIa [27,28]. The identity of the amino acids
responsible for binding of profilins to PI(4,5)-P2 is a mat-
ter of debate, because there are discrepancies between
studies on profilins from lower eukaryotes and from ver-
tebrates [29,30].
Based on comparison of the crystal structure of the two
Acanthamoeba profilin isoforms, Fedorov and co-workers
[31] proposed that a surface with positive electrostatic po-
tential, formed by residues 71, 80, 81 and 115 (corre-
sponding to residues 74, 88, 90 and 125 in human
profilin), was the main PI(4,5)-P2 binding site in Acan-
thamoeba profilin. This surface largely overlaps with the
actin binding surface and hence this model explained the
observed competition between actin and PI(4,5)-P2 for
binding to profilin [3]. Mutagenesis of the yeast homo-
logue partially confirmed this model as residue 71, but
not residue 80, is implicated in phosphoinositide binding
[14]. Based on the structural model, we previously sug-
gested that Glu56 in mammalian profilin IIa would be re-
sponsible for the weaker interaction of this isoform
because the negative charge of this residue reduces the
large, positively charged surface around the hypothetical
PI(4,5)-P2-binding site [27]. In profilin I, which has a ser-
ine at position 56 this is less the case. In human profilin,
however, only Arg88 and not Arg74, was argued to be in-
volved in PI(4,5)-P2-binding since only the mutant in
Arg88 showed decreased inhibition of PI(4,5)-P2 hydrol-
ysis by PLCγ  [32]. We and others have speculated that ba-
sic residues in the carboxy terminal α -helix of vertebrate
profilins may be involved in PI(4,5)-P2-binding. First, Yu
and coworkers [33] postulated that the residues 126 to
136 (KCYEMSHLRR) of human profilin I are a modified
version of the PI(4,5)-P2-binding motif in gelsolin (KS-
GLKYKK). Second, using photoactivatable homologues of
PI(4,5)-P2, it was hypothesized that carboxy terminal ba-
sic residues in human profilin I are involved in contacting
the negative headgroups of PI(4,5)-P2[34]. Third, the ob-
served competition between poly(L-proline) and PI(4,5)-
P2 for binding to profilin [27] is consistent with the pro-
posal that the carboxy terminus of profilin is involved in
PI(4,5)-P2-binding [35]. Fourth, we have shown that
mammalian profilins I and IIa have clearly different affin-
ities for PI(4,5)-P2[27,28], even though their actin bind-
ing surface including Arg74 and Arg88, are well
conserved. This suggests that still other residues must be
involved in PI(4,5)-P2-binding.
In this study we experimentally investigated this hypothe-
sis using site directed mutagenesis of human profilin I.
Our data clearly show that, in addition to Arg88, also
Arg136 in the carboxy terminal helix has a major contri-
bution to PI(4,5)-P2-binding. Given that mutant R136D,
but not R88A, displays wild type actin binding activity, we
propose that the PI(4,5)-P2 and actin binding sites only
partly overlap. Our data also suggest a connection be-
tween PI(4,5)-P2-binding and the interaction with pro-
line-rich ligands, since the profilin IIa mutant W3A,
defective in poly(L-proline) binding shows increased
PI(4,5)-P2-binding. Given the observed conformational
changes upon poly(L-proline) and PI(4,5)-P2-bindingBMC Biochemistry 2002, 3  http://www.biomedcentral.com/1471-2091/3/12
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[27] we propose that correct orientation of the terminal α -
helices is important for ligand binding. This is strength-
ened by the fact that the addition of a myc tag to the car-
boxy terminal helix of profilin IIa abolishes poly(L-
proline) binding completely.
Results and discussion
Mutational analysis of human profilin I
The goal of this study was to get a better insight into the
structural basis of the interaction of vertebrate profilins
with PI(4,5)-P2. To investigate the possible role of the
above mentioned residues (see Background) in PI(4,5)-
P2-binding and to obtain profilins that have reduced
PI(4,5)-P2-binding capacity, we created a set of single and
double mutants in the residues Ser56, Arg74, Arg88,
Arg135 and Arg136 of human profilin I (Figure 1 and Ta-
ble 1) and a mutant W3A defective in poly(L-proline)
binding.
Wild type human profilin I as well as the mutants listed in
Table 1 were expressed in E. coli and all could be purified
by poly(L-proline) affinity chromatography, except for
the W3A mutant which does not bind poly(L-proline)
(see below). We initially included the R88E mutant, but
due to its instability, we were unable to purify this protein
in sufficient amounts for biochemical analysis.
Mutants have a similar fold and stability as wild type pro-
filin I
We first probed whether the introduced mutations did not
affect the conformation and stability by analyzing the
conformational integrity of the mutants using circular di-
chroism (CD) spectra. We measured and compared spec-
tra for wild type and mutant profilins between 184 and
260 nm (Figure 2). All mutants adopt a very similar fold
as wild type profilin I. The wavelengths at which maximal
and minimal peak values are observed do not or only
slightly change. The small shoulders at lower wavelength,
observed for the double mutants with R136D, suggests
that mutation of this residue to aspartic acid affects in
some way the stability or the position of the carboxy ter-
minal α -helix. The differences are however too small to be
interpreted quantitatively.
To further test the stability of the mutants, especially the
ones that show greatly altered binding to PI(4,5)-P2 (see
below), we measured urea denaturation curves (Figure 3).
For R136D and R88A/R136D we observed a very small
shift of the transition to lower urea concentration when
compared to wild type profilin I. On the contrary, R88E/
R136D, which has the most pronounced phenotype (see
below) displays a denaturation curve very similar to that
of wild type profilin I. Together, these data show that the
mutants are stable and correctly folded under the condi-
tions used in the assays described below.
Poly(L-proline) binding
To sensor more subtle effects on the poly(L-proline) bind-
ing of the mutants, we used surface plasmon resonance
technology to monitor the binding of the mutants to the
(GP5)3 peptide derived from VASP. The measured reaso-
nance units (RU) for each mutant at three different con-
centrations are given in Table 1. Although it is not
possible to calculate a Kd for profilin I by this method
[36], from the obtained RU-values we can deduce relative
affinities for the mutants as compared to wild type profi-
lin I (Table 1). The most severe effects are observed for
R135D, R136D and double mutants containing one of
these mutations. This is logical because Arg135 and
Arg136 are located in the carboxy terminal α -helix, which
is involved in poly(L-proline) binding. These residues do,
however, not directly contact the proline-rich peptide nor
do they stabilize any of the crucial poly(L-proline) bind-
ing residues [17,18]. Instead they are oriented outward,
away from the poly(L-proline) moiety in the co-crystal.
Therefore, the mutations may induce a conformational
change in the carboxy terminal helix, which distorts cor-
rect orientation of the poly(L-proline) binding residues.
But as judged from the CD-spectra and modeling experi-
ments, this structural change is probably very subtle (Fig-
ure 2). In addition, mutations may inhibit or facilitate the
previously observed conformational changes that occur in
Table 1: Interaction of wild type and mutant profilins with a pro-
line-rich peptide
R.U. (200 µM) R.U. (140 µM) R.U. (100 µM)
Human profilin 
I
433 318 241
R74A N.T. 240 180
R74E 280 194 146
R88A 280 212 163
S56E 258 211 167
R135D N.T. 80 55
R136D 168 131 93
S56E/R74E N.T. N.T. N.T.
S56E/R74A 224 177 137
S56E/R88E 167 141 105
R74E/R88E N.T. 157 80
R135A/R136A 100 65 43
R88A/R136D 132 121 86
R88E/R136D 152 134 94
W3A N.T. N.T. N.T.
rat profilin IIa 2041 1935 1890
W3A N.T. 43 24
(GP5)3 peptide binding was determined using Biacore technology. The 
reasonance units (R.U.) for three different concentrations of profilin 
were measured. N.T. is not tested.BMC Biochemistry 2002, 3  http://www.biomedcentral.com/1471-2091/3/12
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profilin upon binding of poly(L-proline) [27]. Even
though mutations at positions 56, 74 or 88 and combina-
tions thereof are distant from the poly(L-proline) binding
site, they also result in lowered poly(L-proline) binding.
Remarkably, mutations in this region in yeast profilin
caused a similar phenotype [14]. Apparently these muta-
tions cause allosteric conformational changes, resulting in
less efficient binding of the proline-rich peptide.
Interaction of mutants with actin
We determined the dissociation constants of our mutants
for α -skeletal muscle actin using capped filaments (Table
2). Under these conditions, profilin displays only G-actin
sequestering activity. In addition, we studied the effect of
each mutant on non-steady state actin polymerization
(Figure 4). To analyze the obtained curves we determined
the amount of F-actin formed at a time point (indicated in
Figure 4 as T1/2) where the amount of F-actin in the ab-
sence of profilin is 50% of the amount formed after 1500
sec. In the presence of WT profilin I, only 12% of F-actin
is formed at this time point. The values for the mutant
profilins are given in Table 2.
We could not calculate a Kd value for R74A, R74E, S56E/
R74E, S56E/R74A and R74E/R88E because the concentra-
tion of the actin-profilin complex was nearly zero, leading
to very high Kd estimates. This is consistent with the ob-
servation that these mutants have no activity in the time
course polymerization assay. As determined from the crys-
tal structure of the actin-profilin complex [1] and muta-
genesis studies [37], Arg74 is a crucial residue for actin
binding, since it forms a salt bridge with the carboxyl
group of Phe375. Consequently, changing the arginine to
an alanine or glutamic acid abolishes this interaction
completely. Arg88 is also part of the actin-profilin inter-
face, but changing it to alanine decreases the affinity only
three-fold, indicating that the binding is less stringent
than for Arg74. Mutating Arg88 to leucine [32] or to
glutamic acid in combination with S56E (which on its
own has no effect), however, abolished actin binding
completely. Arg135 and Arg136 locate in the carboxy ter-
minal helix on the opposite side of the molecule (Figure
1) and do not participate in actin binding. As a conse-
quence, mutations in these residues do not affect the af-
finity for actin to a significant extent (Figure 4 and Table
2).
Figure 1
Three dimensional structure of human platelet profilin I (PDB
entry, 1 fik). Helices are shown in red, β -strands in blue, β -
turns in green and loops in grey. Residues mutated in this
study are indicated with space filling: Trp3 in yellow (poly(L-
proline) binding), Ser56 and Arg135 in pink, Arg 74 in green
(actin binding), Arg88 and Arg136 in blue (PI(4,5)-P2 binding).
Figure 2
Circular dichroism spectra show that the mutants have a
similar fold as wild type profilin I. The molar ellipticity per
residue weight is shown. The spectra of several single
mutants (A) and of double mutants with altered PI(4,5)-P2
binding (B) are compared with that of wild type profilin I.
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PI(4,5)-P2 binds to two distinct regions in human profilin I
We used microfiltration and gel filtration to assay the abil-
ity of the mutants to bind PI(4,5)-P2 (Figure 5, Table 3).
The results of both assays were comparable. Based on
analogy with invertebrate profilins (see background) and
combined with sequence comparison of profilin I and IIa,
we expected S56E to contribute negatively to PI(4,5)-P2-
binding. This is, however, not the case and thus this ami-
no acid difference between profilin I and IIa cannot ex-
plain the different affinities of the two profilin isoforms
for PI(4,5)-P2. A further difference with invertebrate pro-
filins is the observation that mutating Arg74 to leucine,
glutamic acid or alanine (this study and [32]) does not
significantly affect PI(4,5)-P2-binding. Since substitution
to an acidic residue at this position results in only a slight
effect, we consider the contribution of Arg74 in PI(4,5)-
P2-binding to be of minor importance. Consequently,
also the double mutants S56E/R74A and S56E/R74E show
nearly wild type PI(4,5)-P2-binding. Previously, it was
shown that Arg88 is involved in PI(4,5)-P2-binding of hu-
man profilin I [32], in agreement with several crystal
structures showing a phosphate or sulfate anion associat-
ed with Arg88 and surrounding residues [38,39]. In our
assays, R88A has a small effect on PI(4,5)-P2-binding (Fig-
ure 5C). Unfortunately we were unable to purify mutant
R88E for which we expected a more pronounced pheno-
type. The effect of the latter mutation can, however, be in-
ferred from the double mutants R74E/R88E and S56E/
R88E. Both mutants show reduced PI(4,5)-P2-binding,
compared to S56E, R74E and S56E/R74E which display
nearly wild type binding capacity (Table 3).
Interestingly, mutant R136D has a more pronounced ef-
fect than R88A (Figure 5C and Table 3). In contrast, mu-
tating the neighboring residue Arg135 has only a small
effect on PI(4,5)-P2-binding. Combining mutations in
Arg88 and Arg136 has an additive effect : R88A/R136D
and R88E/R136D show a much larger reduction in
PI(4,5)-P2-binding than the single mutants (Figure 5C).
This suggests that the reduced PI(4,5)-P2-binding seen for
R136D is due to a direct loss of an interaction. Although
we cannot exclude contribution from allosteric effects,
modeling experiments substituting R136 with an aspartic
acid (data not shown) show no significant change in po-
sition of the side-chain or of the carboxy terminal α -helix.
We conducted gel filtration experiments at high profilin to
PI(4,5)-P2 ratio's for wild type profilin I and the R136D
mutant to assess if the mutation affects overall saturable
binding ability. This seems, however, not to be the case
Table 2: The interaction of wild type and mutant profilins with α -
actin.
Kd(µM) % F-actin at T1/2
Actin - 50
Human profilin I 0.35 12
R74A N.B. 35
R74E N.B. 69
R88A 1.4 23
S56E 0.36 19
R135D 0.4 18
R136D 0.23 16
S56E/R74E N.B. 56
S56E/R74A N.B. 41
S56E/R88E N.B. 43
R74E/R88E N.B. 47
R135A/R136A 0.41 14
R88A/R136D 7.9 57
R88E/R136D 6.6 76
W3A 0.33 N.T.
Rat profilin IIa 0.38 N.T.
W3A 0.18 N.T.
Profilin IIa-myc 0.13 N.T.
The Kd-values were determined using capped filament ends, 5% 
pyrene labeled actin and 1.5 µM profilin. % F-actin at T1/2 is repre-
sentative for the activity of the profilin mutants during actin polymeri-
zation and is derived from curves as in Figure 4. T1/2 is the time point 
where actin alone reaches 50% polymerization. The values in this 
table are averages of three to five different measurements. N.B. indi-
cates no binding and N.T. is not tested.
Figure 3
Urea denaturation curves for human profilin I and the three
mutants that have strongly reduced PI(4,5)-P2 binding. For
each profilin the ratio of the intrinsic fluorescence (F) at two
different wavelengths F(352 nm)/F(332 nm) is plotted versus
the urea concentration. Wild type profilin I (closed squares),
R136D (open circles), R88A/R136D (open triangles), R88E/
R136D (closed circles). The inserted table lists the urea con-
centration at the midpoint of the fluorescence transition.
These values are a measure for the stability of the proteins.
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Hum. profilin I 3.5
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(data not shown), since we found for both wild type and
mutant a ratio of ten profilin molecules per PI(4,5)-P2 mi-
celle, suggesting a stoichiometry of 1:8 profilin : PI(4,5)-
P2 molecules, consistent with a previous report [21]. De-
pending on the assay conditions used, variable values for
the stoichiometry of the profilin : PI(4,5)-P2 complex
were found, varying between 1:4 and 1:10
[3,21,22,25,26]. Given this 1:8 stoichiometry, it is diffi-
cult to observe the loss of one interaction using PI(4,5)-P2
micelles. We note, however, that in case of the mutant
higher concentrations of profilin and PI(4,5)-P2 than for
wild type profilin were required to obtain saturation, in
agreement with the lower affinity of this R136D mutant
Lassing and Lindberg [3] showed that the inhibition on
actin polymerization of wild type human profilin I de-
creases in the presence of PI(4,5)-P2. If Arg136 is involved
in PI(4,5)-P2-binding, then this mutant should be less af-
fected in its inhibitory activity in the presence of PI(4,5)-
P2. This is indeed what we observe (Figure 6). R136D be-
haves similar to wild type profilin I in the absence of
PI(4,5)-P2 (Figure 2 and 6). In the presence of a 9-fold
molar excess of PI(4,5)-P2 we observe, however, a signifi-
cant difference. For R136D we measure only a small re-
duction in sequestering activity compared to an almost
complete inhibition of the sequestering activity of wild
type profilin I. In the presence of a 25-fold molar excess of
PI(4,5)-P2, however, R136D loses its sequestering activity
completely (data not shown), indicating that the muta-
tion did not entirely abolish PI(4,5)-P2-binding. This is
consistent with the results from the gel filtration experi-
ment (Figure 3C) and implicates a role for other residues
such as Arg88.
Recently we demonstrated that profilin IIa has a lower af-
finity for PI(4,5)-P2 than profilin I [28]. This can be ex-
plained with the data presented in this paper. In profilin
I, Arg136 is important for PI(4,5)-P2-binding. In profilin
IIa, there is an aspartic acid at this position (Asp136) and
the profilin I R136D mutant thus mimics the profilin IIa
isoform with respect to PI(4,5)-P2-binding.
An indirect role of tryptophan 3 in PI(4,5)-P2-binding
Based on experiments with photoactivatable PI(4,5)-P2
analogues, Chaudhary and coworkers (1998) [34] sug-
gested that hydrophobic residues in the amino terminal
helix are involved in the interaction with PI(4,5)-P2. Trp3,
the fluorescence of which is quenched in the presence of
PI(4,5)-P2[40], is spatially close to Arg136 (see Figure 1).
Therefore we mutated the former residue to alanine,
thereby reducing the hydrophobic moiety. Trp3 is a cru-
cial residue for the interaction of profilin with poly(L-pro-
Figure 4
Time course of α -actin polymerization in the absence or
presence of several mutant profilins. 10 µM actin and 5 µM
profilin are pre-incubated prior to addition of KCl and MgCl2
to a final concentration of 100 mM and 2 mM, respectively.
Curves for actin alone (closed triangles), or in the presence
of either wild type profilin I (closed circles), R74E (open
squares), R136D (open circles) are shown. T1/2 is the time
point where the F-actin amount in the actin alone sample
reaches 50% of the total F-actin formed after 1500 sec. For
each profilin I mutant the percentage of F-actin at T1/2 is
determined and given in Table 2.
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Table 3: PI(4,5)-P2-binding of mutants assayed by gel filtration
[PI(4,5)-P2]50%
Human profilin I 29
R74A 39
R74E 64
R88A 62
R135D 45
R136D 159
S56E/R74A 44
S56E/R74E 50
S56E/R88E 82
R74E/R88E 85
R135A/R136A 52
R88A/R136D 260
R88E/R136D 679
W3A 30
rat profilin IIa 155
W3A 27
PI(4,5)-P2-binding of mutants assayed by gel filtration (see Figure 5). 
Listed are the PI(4,5)-P2 concentrations where 50% of profilin is 
bound to the PI(4,5)-P2 micelles. In case of R88E/R136D, C50% was 
not reached and the listed value is an extrapolated valueBMC Biochemistry 2002, 3  http://www.biomedcentral.com/1471-2091/3/12
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Figure 5
PI(4,5)-P2-binding of profilin mutants. A. Microfiltration of profilin-PI(4,5)-P2 complexes. 4 µM profilin is incubated with increas-
ing concentrations of PI(4,5)-P2 as indicated and applied to a filter with MWCO of 30.000. Non-bound profilin passes through
the filter upon centrifugation. The flowthrough is analyzed by SDS-PAGE and is shown here for wild type profilin, R135D,
R136D and R135A/R136A. B. Examples of gel filtration experiments. Profilin (10 µM) was pre-incubated with increasing con-
centrations of PI(4,5)-P2 and run over a SMART Superdex75 gel filtration column. Free profilin elutes at 1.62 ml, while the pro-
filin-PI(4,5)-P2 complex elutes in the void (0.96 ml). The profilin peak shifts to the void fraction upon binding to PI(4,5)-P2.
Elution pattern of wild type profilin alone (black line), profilin with 40 µM PI(4,5)-P2 (dark grey line) and profilin with 150 µM
PI(4,5)-P2 (light grey line) are shown. We calculated the peak surface of free profilin to determine the percentage of bound
profilin for different PI(4,5)-P2 concentrations. These data were then plotted in curves as shown in C. C. Percentage of bound
profilin in function of PI(4,5)-P2 concentration as determined from the gel filtration curves. Wild type profilin (closed circle),
R136D (open circle), R88A (closed triangle), R88A/R136D (open triangle) and R88E/R136D (closed square) in the gel filtration
experiment. The concentration of PI(4,5)-P2 where 50% of profilin is bound to the micelles was derived from these curves and
is given in Table 3 for the different mutants.
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line) [2,14–17,41] and as expected the W3A mutants of
profilin I and IIa lack poly(L-proline) binding and were
thus purified using alternative methods (see Materials and
Methods). The dissociation constant for the actin-profilin
I W3A-complex was similar to that of wild type profilin I
(Table 2). The profilin I W3A mutant did not show a sig-
nificant decrease in PI(4,5)-P2-binding, suggesting this
residue does not directly contribute to the interaction. In-
terestingly, the profilin IIa W3A mutant shows increased
affinity for PI(4,5)-P2 and the affinity is comparable with
that of wild type profilin I (Figure 7). Given the profilin I
W3A data presented here and in view of the conforma-
tional changes observed upon ligand binding [27,40], we
propose that mutating Trp3 in profilin IIa promotes/in-
duces a conformation which is more competent for
PI(4,5)-P2-binding (see below).
Model for regulation of profilin-ligand interactions
The data presented here show that in addition to Arg88,
Arg136 is involved in PI(4,5)-P2-binding of mammalian
profilin I. Based on our quantitative gel filtration assay,
the contribution of Arg136 is in fact more important than
that of Arg88 and the double mutant hardly binds
PI(4,5)-P2 micelles. We conclude that the PI(4,5)-P2 bind-
ing sites of profilin are located in two distinct regions of
the molecule that are approximately 31 Å apart (see Figure
1). It is remarkable that there are no corresponding posi-
tively charged residue(s) in the carboxy terminus of yeast
and Acanthamoeba profilins that could account for a simi-
lar interaction as found here for human profilin I. This
may indicate that the structural basis for the interaction of
PI(4,5)-P2 with profilins from lower and higher eukaryo-
tes is partially different. We also note that Acanthamoeba
profilin II has a ten fold lower affinity for PI(4,5)-P2 than
human profilin I [26].
Both PI(4,5)-P2-binding regions in vertebrate profilins are
implicated in the interaction with another profilin ligand.
Arg136 is close to several poly(L-proline) binding resi-
dues. Not surprisingly, mutations in Arg136 have also
strongly decreased poly(L-proline) affinity, although
Arg136 itself is not directly contacting proline-rich lig-
ands. On the other hand, Arg88, involved in PI(4,5)-P2-
binding is also part of the actin binding site [1]. A partial
overlap of actin- and PI(4,5)-P2-binding sites was also ob-
served for actophorin [42] and gelsolin [33,43,44], sug-
gesting this is the basis for a general regulatory
mechanism for several actin binding proteins, whose
function is inhibited by PI(4,5)-P2. Our data thus offer an
explanation for the previously observed competition be-
tween PI(4,5)-P2 and the two other profilin ligands : actin
[3] and poly(L-proline) [27]. This offers a nice model for
the regulation of profilin with its different ligands. Since
PI(4,5)-P2 inhibits both actin and poly(L-proline) bind-
ing [3,27], it is conceivable that PI(4,5)-P2 may have a
master regulatory function in the cell. When PI(4,5)-P2 is
hydrolyzed after cell stimulation, profilin may be set free
to interact both with proteins containing proline-rich re-
gions and with actin to regulate actin dynamics. The con-
Figure 6
PI(4,5)-P2 inefficiently competes with actin for binding to
R136D profilin I. The curves shown are : 8 µM Mg2+-ATP-G-
α -actin (5% pyrene labeled) alone (closed triangles) or with 4
µM wild type profilin I (closed circles), 4 µM R136D (open
circles), 4 µM wild type profilin I and 36 µM PI(4,5)-P2
(closed squares), 4 µM R136D and 36 µM PI(4,5)-P2 (open
squares).
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Profilin IIa W3A mutant has increased affinity for PI(4,5)-P2.
Percentage of bound profilin in function of PI(4,5)-P2 concen-
tration as determined from gel filtration experiments
described in Figure 5B. The concentration of PI(4,5)-P2
where 50% of profilin is bound to the micelles was derived
from these curves and is given in Table 3.
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certed action in vivo of profilin-actin complexes with
several proline-rich proteins such as Ena/VASP proteins,
N-WASP and formins for the promotion of actin polymer-
ization was suggested previously [9,11,45].
Several of our mutants suggest allosteric communication
within vertebrate profilins. Arg88 mutants have reduced
poly(L-proline) binding, although this residue is not part
of the poly(L-proline) binding pocket. Conversely, W3A
(in profilin IIa) influences PI(4,5)-P2-binding, but ap-
pears not to be directly involved in PI(4,5)-P2-binding as
suggested by the data on profilin I W3A, although a W3N
mutation in profilin I results in a higher affinity for
PI(4,5)-P2[46]. These results suggest that the interaction
of profilin with PI(4,5)-P2 and poly(L-proline) involve
conformational changes, which have been experimentally
observed before [27,40]. The interaction of profilin with
PI(4,5)-P2 induces an increase in α -helical content
[22,40]. We propose that the local structure of the neigh-
boring binding sites may change upon binding of PI(4,5)-
P2 and poly(L-proline). The fact that W3A of profilin I
binds PI(4,5)-P2 similar to wild type, suggests that profi-
lin I already has the correct conformation for optimal
binding of PI(4,5)-P2 and that mutating Trp3 to alanine
does not ameliorate this conformation further (see also
below), while an asparagine at position 3 does have a pos-
itive effect [46]. In contrast, the W3A mutation in profilin
IIa increases the affinity for PI(4,5)-P2, suggesting that this
mutation induces a conformational change which opti-
mizes the interaction with PI(4,5)-P2 despite the presence
of an aspartic acid at the nearby position 136. The profilin
IIa structure is, however, optimal for strong poly(L-pro-
line) binding. In modeled and energy minimized profilin
IIa structures we observed that the terminal α -helices are
further apart from each other suggesting better access to
the poly(L-proline) binding cleft [27]. From this point of
view, it is logical to assume that changing the position of
these terminal α -helices has dramatic effects on ligand
binding. This idea is consistent with our observation that
the addition of a myc-tag to the carboxy terminal end of
profilin IIa results in the dramatic loss of poly(L-proline)
binding despite the fact that all known proline interacting
residues are present (Figure 8). The suggested conforma-
tional change in profilin IIa-myc does, however, not sig-
nificantly influence the affinity for actin (Table 2).
Similarly, mouse profilin IIb, which has six additional
amino acids at its carboxy terminus, does not bind poly(L-
proline) [47]. In addition, it has been reported that both
amino- and carboxy terminal GFP fusion proteins of
mammalian profilins display a dramatic loss in po-
ly(Lproline) binding [48,49]. Some fusion proteins even
lack complete poly(L-proline) binding. Therefore we be-
lieve that the correct positioning of the terminal α -helices
of profilin is a primary requirement for ligand interaction.
It is clear that any distortion of the α -helices will reduce
the interaction with poly(L-proline).
Conclusions
We have identified Arg136, besides the previously identi-
fied Arg88, of human profilin I as an important residue
for the interaction with PI(4,5)-P2. Since Arg136 is part of
the poly(L-proline) binding helix and Arg88 is located in
the actin binding surface, we suggest that the interaction
of profilin with its different ligands is regulated by com-
petitive interactions, which may be partly allosteric. Our
results also indicate that the position of the two large ter-
minal α -helices is crucial for optimal ligand binding. The
Figure 8
Addition of carboxy terminal myc-tag to profilin IIa dramati-
cally reduces poly(L-proline) binding. A. Biacore binding
curves for 100 µM wild type profilin IIa (blue), 1 µM wild type
profilin IIa (green), or 100 µM profilin IIa-myc (red) to the
(GP5)3 peptide derived from VASP. Resonance units (R.U.)
are a measure for the number of profilin molecules retained
by the peptide on the sensor chip and this is also concentra-
tion dependent (see B.). Even at a 100 times higher concen-
tration, profilin IIa-myc (100 µM) binds less efficient to the
peptide than wild type profilin IIa (1 µM). B. R.U. values
obtained with different concentrations of wild type profilin
IIa and profilin IIa-myc. Note that the value for 100 µM wild
type profilin IIa is different from the one in Table 1, due to a
different amount of peptide coupled to the sensor chip.
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addition of (protein or peptide) tags to the carboxy termi-
nus results in dramatic decreased affinity for poly(L-pro-
line) ligands. Conceivably, this will result in altered
interactions in cells and in vivo data obtained with tagged
profilin isoforms should be carefully (re)interpreted.
Materials and methods
Profilin mutagenesis and purification
The profilin I cDNA amplified by polymerase chain reac-
tion from a human cDNA library was subcloned into
pET11d [28]. Site directed mutagenesis was performed by
polymerase chain reaction with mutated oligonucleotide
primers and pfu polymerase. Mutations were verified by
sequencing. MC1061 E. coli harboring the pT7POL26
plasmid [50] were used for expression of wild type and
mutant profilin I, Proteins were subsequently purified by
poly(L-proline) affinity chromatography [28]. W3A mu-
tants do not bind poly(L-proline), thus the flow-through
of the poly(L-proline) column was loaded onto a DEAE
column equilibrated in buffer A (20 mM Tris-HCl, pH 8.1,
1 mM EDTA, 1 mM DTT). The column was eluted with a
0 to 500 mM NaCl gradient in buffer A. Profilin eluted
with 60 to 130 mM NaCl. The profilin containing frac-
tions were pooled and loaded on a MonoQ column. The
flowthrough of this column contained profilin and only
very few other proteins. These contaminating proteins
were then removed by gel filtration in buffer A.
Other Protein preparations
We purified actin from rabbit skeletal muscle and isolated
it as calcium G-actin by Sephadex G200 chromatography
in G-buffer (5 mM Tris-HCl, pH 7.7, 0.1 mM CaCl2, 0.2
mM ATP, 0.2 mM dithiothreitol, 0.01% sodium azide)
[51,52]. Actin was pyrene labeled on cysteine 375 [53].
Gelsolin was purified from human plasma [54].
Circular dichroism
We performed CD measurements in the far UV region
(184–260 nm) for WT and mutant profilins at a concen-
tration of 15 µM in 7 mM TRIS/HCl, pH 8 in a JASCO J-
170 spectropolarimeter using a 1 cm pathway cell. The
step resolution was 0.5 nm and the scan speed 20 nm/
min. For each sample the average of 9 scans was obtained
and spectra were normalized for concentrations.
Denaturation curves
Profilin was diluted to 2 µM in increasing concentrations
of urea (0 to 8 M) in 20 mM Tris-HCl pH 8.1, 1 mM EDTA,
1 mM DTT. The samples were incubated for 15 min. at
room temperature and the intrinsic fluorescence change
during a wavelength scan between 300 and 400 nm was
measured in a Hitachi F4500 spectrophotometer with the
excitation wavelength set at 295 nm. We recorded a shift
of the emission peak from 332 nm to 352 nm upon dena-
turation with urea. For each sample we plotted the ratio
F(352 nm)/F(332 nm) versus the concentration of urea in
that sample (see Figure 3) [55].
Polyproline binding
A (GP5)3 peptide, derived from VASP, was used to com-
pare the affinities of the profilin I mutants on a BiacoreX
(Pharmacia). The amino terminally biotinylated peptide
was coupled to a streptavidin coated Biacore biosensor
chip (Pharmacia). The experiments were carried out and
analyzed as described in [36].
Actin binding assays
The affinity of the profilin mutants for α -actin was deter-
mined using gelsolin capped filaments as described in [6].
To determine the effect on non-steady state actin polym-
erization we pre-incubated 10 µM actin (5 % pyrene la-
beled) with or without 5 µM profilin for 15 minutes at
room temperature prior to the addition of a final concen-
tration of 2 mM MgCl2 and 100 mM KCl. The fluores-
cence change was recorded using a Hitachi F4500
spectrophotometer.
PI(4,5)-P2-binding
Microfiltration was performed as described [27] using 4
µM profilin and different concentrations of PI(4,5)-P2
(Sigma) as indicated in Figure 3A. For gel filtration exper-
iments, 10 µM profilin was pre-incubated with PI(4,5)-P2
micelles for 30 min on ice prior to loading on a
Superdex75 gel filtration column (SMART, Pharmacia).
The peak surface of free profilin was determined and used
to calculate the percentage of bound and free profilin in
each sample.
The competition experiment between actin and PI(4,5)-P2
was performed with 8 µM Mg2+-ATP-G-α -actin (5%
pyrene labeled), 4 µM profilin and 36 µM PI(4,5)-P2 in 5
mM Tris-HCl, 0.2 mM ATP, 0.2 mM dithiothreitol, pH 7
in the absence of Ca2+ and Mg2+ to avoid precipitation of
PI(4,5)-P2. Profilin and PI(4,5)-P2-micelles were incubat-
ed for 10 minutes on ice prior to addition of actin and
subsequent incubation for 10 minutes at room tempera-
ture. Polymerization was started by adding KCl to a final
concentration of 50 mM.
Abbreviations
Circular dichroism : CD; enabled : Ena; phosphatidyli-
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reasonance units : RU.
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